PerturbAI
In vivo CRISPR atlases and AI for causal drug discovery
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
PerturbAI combines scalable in vivo CRISPR perturbation with AI to map how disease genes control cells and circuits in living organisms. The company generates organism-scale perturbation atlases linking genes to cells, circuits and disease, then trains biological models intended to predict how genes and drugs reshape biological systems and accelerate therapeutics discovery.
- Website
- perturb.ai
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- PerturbAI Engine — Causal gene-to-circuit models from in vivo CRISPR atlases · Saas